Related references
Note: Only part of the references are listed.Is olive oil good for you? A systematic review and meta-analysis on anti-inflammatory benefits from regular dietary intake
Joao Fernandes et al.
NUTRITION (2020)
Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
Hajime Yamakage et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
Euglycemic diabetic ketoacidosis
Leonid Barski et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis
Jerome Bellenger et al.
BIOCHIMIE (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dietary survey in Japanese patients with type 2 diabetes and the influence of dietary carbohydrate on glycated hemoglobin: The Sleep and Food Registry in Kanagawa study
Tadashi Yamakawa et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice
Kazuno Omori et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions
Junki Miyamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Naba Saeed et al.
NUTRIENTS (2019)
Comparison of efficacy of low-carbohydrate and low-fat diet education programs in non-alcoholic fatty liver disease: A randomized controlled study
Eun Chul Jang et al.
HEPATOLOGY RESEARCH (2018)
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Dustin M. Lee et al.
CARDIOVASCULAR DIABETOLOGY (2018)
SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL
Matthew A. Cavender et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
John A. Batsis et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
Volker Vallon et al.
DIABETOLOGIA (2017)
Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice
Farhana Naznin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
Liang Xu et al.
EBIOMEDICINE (2017)
Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial
Daisuke Ito et al.
DIABETES CARE (2017)
Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study
Daisuke Yabe et al.
DIABETES OBESITY & METABOLISM (2017)
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
Wataru Ogawa et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
Seizo Okauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
Simon A. Hawley et al.
DIABETES (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals
Sabri Ahmed Rial et al.
NUTRIENTS (2016)
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
Chikara Komiya et al.
PLOS ONE (2016)
Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice
Kuralay Atageldiyeva et al.
PLOS ONE (2016)
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Peter P. Toth
VASCULAR HEALTH AND RISK MANAGEMENT (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Non-calorie-restricted Low-carbohydrate Diet is Effective as an Alternative Therapy for Patients with Type 2 Diabetes
Yoshifumi Yamada et al.
INTERNAL MEDICINE (2014)
Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults A Meta-analysis
Bradley C. Johnston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
F. L. Santos et al.
OBESITY REVIEWS (2012)
Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling
Jeremie Boucher et al.
NATURE COMMUNICATIONS (2012)
Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein
Maximilian Bielohuby et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Early Growth Retardation and Insulin Resistance in JAZF1 KO Mice
Hui-Young Lee et al.
DIABETES (2011)
SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
Michael J. Jurczak et al.
DIABETES (2011)
Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality Two Cohort Studies
Teresa T. Fung et al.
ANNALS OF INTERNAL MEDICINE (2010)
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet
Iris Shai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Low-carbohydrate-diet score and the risk of coronary heart disease in women
Thomas L. Halton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
QM Anstee et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2006)
Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats
L Ghibaudi et al.
OBESITY RESEARCH (2002)
Share Paper
